FLUTICASONE PROPIONATE AND SALMETEROL XINAFOATE

FLUTICASONE PROPIONATE AND SALMETEROL XINAFOATE was reported 60266 times

These side effects are most commonly reported by patients taking FLUTICASONE PROPIONATE AND SALMETEROL XINAFOATE:

# Side effect Count
0 DYSPNOEA 10067
1 ASTHMA 8223
2 DRUG INEFFECTIVE 5535
3 PNEUMONIA 4989
4 COUGH 4984
5 WHEEZING 4239
6 FATIGUE 3968
7 HEADACHE 3663
8 MALAISE 3642
9 PAIN 3429
10 OFF LABEL USE 2872
11 NAUSEA 2761
12 DIARRHOEA 2235
13 VOMITING 2205
14 DIZZINESS 2173
15 NASOPHARYNGITIS 2173
16 PRODUCTIVE COUGH 2152
17 WEIGHT DECREASED 2129
18 DRUG HYPERSENSITIVITY 2073
19 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 2001
20 FALL 1995
21 PYREXIA 1964
22 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 1960
23 RASH 1939
24 ARTHRALGIA 1896
25 CHEST DISCOMFORT 1864
26 DEATH 1776
27 HYPERSENSITIVITY 1773
28 CHEST PAIN 1748
29 CONDITION AGGRAVATED 1733
30 ASTHENIA 1721
31 BACK PAIN 1711
32 BRONCHITIS 1628
33 PRODUCT QUALITY ISSUE 1622
34 SINUSITIS 1595
35 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 1583
36 ANXIETY 1574
37 HYPERTENSION 1573
38 PAIN IN EXTREMITY 1551
39 WEIGHT INCREASED 1489
40 INFLUENZA 1469
41 PRURITUS 1459
42 INSOMNIA 1392
43 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 1381
44 PRODUCT DOSE OMISSION ISSUE 1380
45 BLOOD PRESSURE INCREASED 1346
46 OBSTRUCTIVE AIRWAYS DISORDER 1329
47 DYSPHONIA 1293
48 INFECTION 1293
49 CONSTIPATION 1264
50 UPPER RESPIRATORY TRACT INFECTION 1260
51 HEART RATE INCREASED 1178
52 PRODUCT USE ISSUE 1167
53 DYSPNOEA EXERTIONAL 1117
54 NASAL CONGESTION 1117
55 FEELING ABNORMAL 1090
56 ERYTHEMA 1076
57 HOSPITALISATION 1062
58 DRUG DOSE OMISSION 1055
59 OROPHARYNGEAL PAIN 1047
60 HYPERHIDROSIS 997
61 PERIPHERAL SWELLING 996
62 LUNG DISORDER 960
63 RHEUMATOID ARTHRITIS 958
64 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 952
65 URTICARIA 939
66 URINARY TRACT INFECTION 931
67 OXYGEN SATURATION DECREASED 925
68 ABDOMINAL PAIN 921
69 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 920
70 RHINORRHOEA 913
71 PRODUCT USE IN UNAPPROVED INDICATION 896
72 JOINT SWELLING 889
73 DEPRESSION 881
74 CHRONIC KIDNEY DISEASE 877
75 OEDEMA 876
76 INTENTIONAL PRODUCT MISUSE 872
77 RESPIRATORY TRACT INFECTION 869
78 GAIT DISTURBANCE 861
79 OVERDOSE 860
80 ABDOMINAL PAIN UPPER 852
81 COVID-19 849
82 DECREASED APPETITE 844
83 SPUTUM DISCOLOURED 844
84 MUSCLE SPASMS 837
85 LOWER RESPIRATORY TRACT INFECTION 830
86 FLUID RETENTION 829
87 INJECTION SITE PAIN 813
88 TREMOR 789
89 GASTROOESOPHAGEAL REFLUX DISEASE 784
90 MYALGIA 776
91 ILLNESS 765
92 HEPATIC ENZYME INCREASED 734
93 ABDOMINAL DISCOMFORT 718
94 CONTUSION 711
95 RENAL FAILURE 711
96 ACUTE KIDNEY INJURY 706
97 RASH ERYTHEMATOUS 706
98 INFUSION RELATED REACTION 692
99 INCORRECT DOSE ADMINISTERED 683
100 DRUG INTOLERANCE 682
101 IMMUNODEFICIENCY 680
102 FOOD ALLERGY 666
103 BLOOD COUNT ABNORMAL 662
104 FULL BLOOD COUNT ABNORMAL 661
105 SOMNOLENCE 660
106 MEMORY IMPAIRMENT 650
107 HYPOTENSION 649
108 STRESS 642
109 THROMBOSIS 638
110 FORCED EXPIRATORY VOLUME DECREASED 637
111 OEDEMA PERIPHERAL 634
112 CARDIAC FAILURE CONGESTIVE 630
113 PALPITATIONS 611
114 ALOPECIA 606
115 WRONG TECHNIQUE IN DEVICE USAGE PROCESS 604
116 CHILLS 597
117 MYOCARDIAL INFARCTION 596
118 ARTHRITIS 590
119 RESPIRATORY DISORDER 590
120 EXPOSURE DURING PREGNANCY 582
121 CATARACT 580
122 PULMONARY EMBOLISM 576
123 PHARMACEUTICAL PRODUCT COMPLAINT 568
124 PSORIASIS 561
125 HYPOAESTHESIA 556
126 CEREBROVASCULAR ACCIDENT 537
127 THROAT IRRITATION 532
128 BLOOD GLUCOSE INCREASED 530
129 MIDDLE INSOMNIA 530
130 MIGRAINE 528
131 ANAEMIA 523
132 ATRIAL FIBRILLATION 521
133 UNDERDOSE 516
134 VISION BLURRED 515
135 DRUG ADMINISTRATION ERROR 514
136 ILL-DEFINED DISORDER 511
137 LOSS OF CONSCIOUSNESS 511
138 SLEEP DISORDER 508
139 DRY MOUTH 506
140 HYPOXIA 499
141 DIABETES MELLITUS 498
142 SWELLING 496
143 CARDIAC DISORDER 494
144 RESPIRATORY TRACT CONGESTION 491
145 BURSITIS 490
146 HAEMOPTYSIS 490
147 PRESCRIBED OVERDOSE 487
148 COELIAC DISEASE 484
149 PARAESTHESIA 483
150 DYSPEPSIA 481
151 INTENTIONAL PRODUCT USE ISSUE 481
152 CONFUSIONAL STATE 479
153 DEHYDRATION 479
154 DYSPHAGIA 479
155 TEMPERATURE REGULATION DISORDER 478
156 GASTROINTESTINAL HAEMORRHAGE 473
157 BLOOD PRESSURE SYSTOLIC INCREASED 463
158 VISUAL IMPAIRMENT 453
159 THROMBOCYTOPENIA 440
160 INFLUENZA LIKE ILLNESS 436
161 DRY SKIN 427
162 VIRAL INFECTION 424
163 SEPSIS 420
164 CONTRAINDICATED PRODUCT ADMINISTERED 398
165 HERPES ZOSTER 398
166 EPISTAXIS 397
167 NEUROPATHY PERIPHERAL 394
168 THERAPEUTIC RESPONSE DECREASED 387
169 MUSCULOSKELETAL STIFFNESS 385
170 ABDOMINAL DISTENSION 381
171 SYNCOPE 379
172 GENERAL PHYSICAL HEALTH DETERIORATION 378
173 TREATMENT FAILURE 378
174 BRONCHIECTASIS 377
175 SEASONAL ALLERGY 376
176 NODULE 371
177 LUNG INFECTION 367
178 NECK PAIN 366
179 MUSCULAR WEAKNESS 361
180 PRODUCT DOSE OMISSION 359
181 LUNG NEOPLASM MALIGNANT 358
182 APHONIA 355
183 BALANCE DISORDER 352
184 ECZEMA 349
185 PULMONARY MASS 347
186 OSTEOPOROSIS 346
187 TACHYCARDIA 346
188 EMPHYSEMA 341
189 BLOOD PRESSURE DECREASED 339
190 SINUS DISORDER 339
191 HAEMOGLOBIN DECREASED 338
192 EOSINOPHIL COUNT INCREASED 337
193 INFECTIVE PULMONARY EXACERBATION OF CYSTIC FIBROSIS 334
194 DUST ALLERGY 333
195 DISCOMFORT 328
196 PULMONARY OEDEMA 328
197 ORAL CANDIDIASIS 327
198 HYPOTHYROIDISM 326
199 DEVICE USE ERROR 325
200 RESPIRATORY FAILURE 325
201 SURGERY 325
202 CANDIDA INFECTION 323
203 INJECTION SITE ERYTHEMA 322
204 PRODUCT COMPLAINT 321
205 NO ADVERSE EVENT 320
206 HAEMORRHAGE 317
207 ANAPHYLACTIC REACTION 314
208 FLUSHING 313
209 EAR INFECTION 312
210 NERVOUSNESS 310
211 SEIZURE 307
212 OSTEOARTHRITIS 306
213 SNEEZING 306
214 CELLULITIS 305
215 DYSGEUSIA 303
216 TREATMENT NONCOMPLIANCE 303
217 CONJUNCTIVITIS ALLERGIC 300
218 ADVERSE EVENT 298
219 SLEEP APNOEA SYNDROME 298
220 BREATH SOUNDS ABNORMAL 296
221 NEPHROLITHIASIS 296
222 MITE ALLERGY 295
223 ARTERIOSCLEROSIS CORONARY ARTERY 294
224 BLOOD IMMUNOGLOBULIN E INCREASED 292
225 PULMONARY FUNCTION TEST DECREASED 292
226 SPIROMETRY ABNORMAL 292
227 SECRETION DISCHARGE 289
228 EMOTIONAL DISTRESS 286
229 MOBILITY DECREASED 285
230 SWELLING FACE 280
231 ARTERIOSCLEROSIS 278
232 MYCOTIC ALLERGY 278
233 ADVERSE DRUG REACTION 277
234 BODY TEMPERATURE DECREASED 277
235 FOETAL DEATH 277
236 RESPIRATORY SYMPTOM 276
237 DEVICE MALFUNCTION 275
238 MUSCULOSKELETAL PAIN 275
239 UPPER-AIRWAY COUGH SYNDROME 275
240 NASAL OEDEMA 274
241 SKIN EXFOLIATION 274
242 RALES 273
243 ROAD TRAFFIC ACCIDENT 273
244 RASH PRURITIC 270
245 GASTROINTESTINAL DISORDER 268
246 VERTIGO 267
247 RESPIRATORY RATE INCREASED 265
248 HEART RATE DECREASED 264
249 PULMONARY FIBROSIS 263
250 SPEECH DISORDER 261
251 EOSINOPHILIC GRANULOMATOSIS WITH POLYANGIITIS 260
252 NASAL POLYPS 260
253 NORMOCHROMIC NORMOCYTIC ANAEMIA 260
254 DRUG INTERACTION 256
255 SUICIDAL IDEATION 256
256 THERAPEUTIC RESPONSE UNEXPECTED 255
257 EYE PRURITUS 253
258 HOT FLUSH 253
259 BURNING SENSATION 251
260 INJURY 247
261 LIMB INJURY 246
262 DRY EYE 245
263 END STAGE RENAL DISEASE 245
264 IMPAIRED QUALITY OF LIFE 245
265 PLEURAL EFFUSION 245
266 SINUS CONGESTION 244
267 UNEVALUABLE EVENT 244
268 BLOOD CHOLESTEROL INCREASED 242
269 FUNGAL INFECTION 242
270 FEELING HOT 241
271 DERMATITIS ATOPIC 239
272 INJECTION SITE BRUISING 238
273 DEPRESSED MOOD 237
274 AMNESIA 236
275 DEVICE ISSUE 234
276 OBESITY 233
277 CYSTIC FIBROSIS 232
278 TYPE 2 DIABETES MELLITUS 229
279 EAR PAIN 225
280 RHINITIS 223
281 BONE PAIN 220
282 FLATULENCE 219
283 INJECTION SITE SWELLING 219
284 RIB FRACTURE 219
285 STOMATITIS 219
286 CYSTITIS 218
287 HYPOACUSIS 218
288 THROAT TIGHTNESS 218
289 ARTHROPATHY 217
290 EYE DISORDER 214
291 INFLAMMATION 214
292 MULTIPLE ALLERGIES 214
293 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 213
294 CARDIAC FAILURE 212
295 EXPIRED PRODUCT ADMINISTERED 212
296 PULMONARY CONGESTION 212
297 EYE PAIN 211
298 NEOPLASM MALIGNANT 211
299 JOINT INJURY 209
300 HIP FRACTURE 207
301 WHITE BLOOD CELL COUNT INCREASED 207
302 MEDICATION ERROR 206
303 RENAL DISORDER 206
304 THERAPY CESSATION 205
305 ACUTE RESPIRATORY FAILURE 204
306 THYROID DISORDER 204
307 DISEASE RECURRENCE 202
308 DIVERTICULITIS 202
309 BLOOD CREATININE INCREASED 201
310 INTESTINAL OBSTRUCTION 201
311 CHRONIC SINUSITIS 200
312 INJECTION SITE PRURITUS 200
313 LACRIMATION INCREASED 200
314 PERICARDIAL EFFUSION 199
315 STAPHYLOCOCCAL INFECTION 198
316 RETCHING 195
317 BLOOD POTASSIUM DECREASED 192
318 BLOOD PRESSURE FLUCTUATION 192
319 CARDIAC ARREST 192
320 DRUG DOSE OMISSION BY DEVICE 192
321 BLISTER 191
322 FOOT FRACTURE 190
323 TRANSIENT ISCHAEMIC ATTACK 190
324 LARYNGITIS 188
325 PNEUMONITIS 188
326 HALLUCINATION 187
327 WHITE BLOOD CELL COUNT DECREASED 187
328 EYE IRRITATION 186
329 LETHARGY 186
330 FIBROMYALGIA 185
331 RENAL INJURY 184
332 HEART RATE IRREGULAR 183
333 RECTAL HAEMORRHAGE 183
334 MATERNAL EXPOSURE DURING PREGNANCY 182
335 AGITATION 181
336 CHOKING 181
337 INTERVERTEBRAL DISC PROTRUSION 180
338 DRUG EFFECT INCOMPLETE 179
339 RESPIRATORY DISTRESS 179
340 SKIN DISCOLOURATION 179
341 VASCULITIS 179
342 DEEP VEIN THROMBOSIS 178
343 PLATELET COUNT DECREASED 177
344 RESPIRATION ABNORMAL 177
345 DEVICE DELIVERY SYSTEM ISSUE 176
346 HAEMATOCHEZIA 176
347 IRRITABILITY 176
348 LOCALISED INFECTION 175
349 ASTHMA-CHRONIC OBSTRUCTIVE PULMONARY DISEASE OVERLAP SYNDROME 174
350 BREAST CANCER 174
351 PANIC ATTACK 173
352 DISEASE PROGRESSION 172
353 INJECTION SITE REACTION 172
354 LIMB DISCOMFORT 172
355 ORAL PAIN 172
356 POOR QUALITY SLEEP 172
357 SENSITIVITY TO WEATHER CHANGE 171
358 BACTERIAL INFECTION 170
359 GLAUCOMA 168
360 GASTROENTERITIS VIRAL 166
361 HERNIA 165
362 OCULAR HYPERAEMIA 165
363 PULMONARY HYPERTENSION 165
364 EYE SWELLING 164
365 RENAL IMPAIRMENT 164
366 SKIN LESION 164
367 HYPERSOMNIA 163
368 HYPOVENTILATION 163
369 LIP SWELLING 161
370 PULMONARY ALVEOLAR HAEMORRHAGE 161
371 FEELING JITTERY 160
372 NEURITIS 160
373 POLLAKIURIA 160
374 EOSINOPHILIA 159
375 HEAD INJURY 159
376 DISTURBANCE IN ATTENTION 158
377 DRUG EFFECT DECREASED 158
378 GAIT INABILITY 158
379 HYPONATRAEMIA 158
380 NEUROLOGICAL SYMPTOM 158
381 DYSURIA 157
382 ACCIDENTAL EXPOSURE TO PRODUCT 156
383 ARRHYTHMIA 156
384 CHOLELITHIASIS 155
385 EYE HAEMORRHAGE 154
386 MUSCULOSKELETAL CHEST PAIN 154
387 THERAPEUTIC PRODUCT EFFECT DECREASED 154
388 TINNITUS 154
389 ANKLE FRACTURE 153
390 ACNE 152
391 GOUT 152
392 RHINITIS ALLERGIC 152
393 WOUND 151
394 GASTRIC DISORDER 150
395 OSTEOPENIA 150
396 UPPER LIMB FRACTURE 149
397 ANGIOEDEMA 148
398 NEURALGIA 148
399 CROHN^S DISEASE 147
400 ANGINA PECTORIS 146
401 BRONCHOSPASM 146
402 PRODUCT SUBSTITUTION ISSUE 146
403 PULMONARY VASCULITIS 146
404 BLINDNESS 145
405 DECREASED ACTIVITY 145
406 THERAPY INTERRUPTED 145
407 HIATUS HERNIA 144
408 INJECTION SITE HAEMORRHAGE 143
409 INTERSTITIAL LUNG DISEASE 143
410 SKIN DISORDER 143
411 MUSCULOSKELETAL DISCOMFORT 142
412 BLOOD TEST ABNORMAL 141
413 ADRENAL INSUFFICIENCY 140
414 EXTRA DOSE ADMINISTERED 140
415 INVESTIGATION 139
416 LYMPHADENOPATHY 139
417 MALNUTRITION 138
418 MOVEMENT DISORDER 136
419 PANCREATITIS 136
420 PRODUCT STORAGE ERROR 136
421 KIDNEY INFECTION 135
422 PROSTATE CANCER 135
423 NIGHT SWEATS 134
424 PNEUMOTHORAX 134
425 MACULAR DEGENERATION 133
426 NEPHROGENIC ANAEMIA 133
427 INFUSION SITE PAIN 132
428 ANHEDONIA 131
429 HAEMATURIA 131
430 FEELING COLD 130
431 MENTAL DISORDER 130
432 PULMONARY FUNCTION TEST ABNORMAL 130
433 RASH MACULAR 130
434 SWOLLEN TONGUE 130
435 BLOOD GLUCOSE DECREASED 128
436 PAIN IN JAW 127
437 SINUS PAIN 127
438 INCORRECT ROUTE OF DRUG ADMINISTRATION 126
439 PHARYNGITIS 126
440 BODY TEMPERATURE INCREASED 125
441 DRY THROAT 125
442 LIGAMENT SPRAIN 124
443 CLOSTRIDIUM DIFFICILE INFECTION 123
444 INHALATION THERAPY 123
445 THROAT CLEARING 123
446 SKIN LACERATION 122
447 SPINAL FRACTURE 122
448 DEMENTIA 121
449 RED BLOOD CELL COUNT DECREASED 120
450 CONJUNCTIVITIS 118
451 INSURANCE ISSUE 117
452 TOOTH ABSCESS 117
453 INTENTIONAL DOSE OMISSION 116
454 ANGER 115
455 BODY HEIGHT DECREASED 115
456 FEEDING DISORDER 115
457 INABILITY TO AFFORD MEDICATION 115
458 PNEUMONIA BACTERIAL 115
459 RESPIRATORY ARREST 115
460 KNEE ARTHROPLASTY 114
461 POLYP 114
462 RESTRICTIVE PULMONARY DISEASE 114
463 SKIN IRRITATION 114
464 TOTAL LUNG CAPACITY ABNORMAL 114
465 NASAL DISCHARGE DISCOLOURATION 113
466 PULMONARY THROMBOSIS 112
467 RHONCHI 112
468 GASTROENTERITIS 111
469 MULTI-ORGAN DISORDER 111
470 PRE-EXISTING CONDITION IMPROVED 111
471 DISABILITY 110
472 LOWER LIMB FRACTURE 110
473 MULTIPLE SCLEROSIS RELAPSE 110
474 OROPHARYNGEAL DISCOMFORT 110
475 UNRESPONSIVE TO STIMULI 110
476 WRIST FRACTURE 110
477 AGEUSIA 109
478 TOOTH DISORDER 109
479 TOOTHACHE 109
480 BONE DISORDER 108
481 BLOOD SODIUM DECREASED 107
482 BONE DENSITY DECREASED 107
483 DRUG DEPENDENCE 107
484 AGGRESSION 105
485 DISORIENTATION 105
486 INCREASED BRONCHIAL SECRETION 105
487 INFUSION SITE ERYTHEMA 105
488 LIVER DISORDER 105
489 LOWER RESPIRATORY TRACT CONGESTION 105
490 POST PROCEDURAL COMPLICATION 105
491 SYSTEMIC LUPUS ERYTHEMATOSUS 105
492 THERAPY NON-RESPONDER 105
493 TOTAL LUNG CAPACITY DECREASED 105
494 CORONARY ARTERY DISEASE 104
495 HYPOKALAEMIA 104
496 INFUSION SITE SWELLING 103
497 PSEUDOMONAS INFECTION 103
498 URINARY INCONTINENCE 103
499 BLOOD PRESSURE DIASTOLIC DECREASED 102
500 COLITIS ULCERATIVE 102
501 IMPAIRED HEALING 102
502 INTENTIONAL UNDERDOSE 102
503 THERAPEUTIC RESPONSE SHORTENED 102
504 DECREASED IMMUNE RESPONSIVENESS 101
505 HEPATIC STEATOSIS 101
506 APPETITE DISORDER 100
507 HAEMORRHOIDS 100
508 REVERSIBLE AIRWAYS OBSTRUCTION 100
509 URINARY RETENTION 100
510 ABASIA 99
511 ANTINEUTROPHIL CYTOPLASMIC ANTIBODY POSITIVE 99
512 DERMATITIS CONTACT 98
513 PRESYNCOPE 98
514 PRODUCT DOSE OMISSION IN ERROR 98
515 SARCOIDOSIS 98
516 ASPHYXIA 97
517 DRUG ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE 97
518 HAEMATOMA 97
519 NASAL OBSTRUCTION 97
520 ROTATOR CUFF SYNDROME 97
521 SINUS TACHYCARDIA 97
522 SPINAL OSTEOARTHRITIS 97
523 TOOTH INFECTION 97
524 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 96
525 JOINT STIFFNESS 96
526 LEUKOPENIA 96
527 NEUTROPENIA 96
528 PALLOR 96
529 SCAR 96
530 BACK INJURY 95
531 CARDIAC MURMUR 95
532 INJECTION SITE MASS 95
533 NIGHTMARE 95
534 PRURITUS GENERALISED 95
535 RESTLESS LEGS SYNDROME 95
536 PHARYNGEAL OEDEMA 94
537 BACK DISORDER 93
538 BLOOD URINE PRESENT 93
539 GALLBLADDER DISORDER 93
540 ULCER 93
541 VISUAL ACUITY REDUCED 93
542 ACCIDENT 92
543 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 92
544 CRYING 92
545 EAR DISCOMFORT 92
546 FEAR 92
547 GASTRIC ULCER 92
548 ORAL HERPES 92
549 BLOOD PRESSURE SYSTOLIC ABNORMAL 91
550 CATARACT OPERATION 91
551 DELIRIUM 91
552 HYPERCHOLESTEROLAEMIA 91
553 PROCEDURAL PAIN 91
554 ANOSMIA 90
555 APHASIA 90
556 BRONCHIAL DISORDER 90
557 COGNITIVE DISORDER 90
558 CONCUSSION 90
559 FEMUR FRACTURE 90
560 FLANK PAIN 90
561 PHARYNGITIS STREPTOCOCCAL 90
562 SKIN ULCER 90
563 BLOOD IRON DECREASED 89
564 BLOOD PRESSURE DIASTOLIC ABNORMAL 89
565 MALIGNANT NEOPLASM PROGRESSION 89
566 TENDERNESS 89
567 TENDONITIS 89
568 ABNORMAL DREAMS 87
569 CARPAL TUNNEL SYNDROME 87
570 GLOSSODYNIA 87
571 INJECTION SITE RASH 87
572 LABORATORY TEST ABNORMAL 87
573 MYCOBACTERIUM AVIUM COMPLEX INFECTION 87
574 ORAL DISCOMFORT 87
575 VITAMIN D DEFICIENCY 87
576 ABNORMAL BEHAVIOUR 86
577 ASCITES 86
578 ASPIRATION 86
579 BLOOD PRESSURE ABNORMAL 86
580 DYSSTASIA 86
581 IMPAIRED WORK ABILITY 86
582 INTERVERTEBRAL DISC DEGENERATION 86
583 LUNG HYPERINFLATION 86
584 PSORIATIC ARTHROPATHY 86
585 SARS-COV-2 TEST POSITIVE 86
586 SEPTIC SHOCK 86
587 ATELECTASIS 85
588 EXPOSURE VIA SKIN CONTACT 85
589 HEAD DISCOMFORT 85
590 INCREASED UPPER AIRWAY SECRETION 85
591 PULMONARY ARTERIAL HYPERTENSION 85
592 SCRATCH 85
593 SPINAL OPERATION 85
594 ACUTE MYOCARDIAL INFARCTION 84
595 C-REACTIVE PROTEIN INCREASED 84
596 COLD SWEAT 84
597 COLITIS 84
598 DEAFNESS 84
599 FAECES DISCOLOURED 84
600 GASTRITIS 84
601 HYPOPHAGIA 84
602 LIVER FUNCTION TEST INCREASED 84
603 PROLONGED EXPIRATION 84
604 COMA 83
605 ECONOMIC PROBLEM 83
606 ALLERGY TO ANIMAL 82
607 CANDIDIASIS 82
608 EATING DISORDER 82
609 HAEMATOCRIT DECREASED 82
610 IMMUNE SYSTEM DISORDER 82
611 THINKING ABNORMAL 82
612 ASPARTATE AMINOTRANSFERASE INCREASED 81
613 MULTIPLE SCLEROSIS 81
614 RESTLESSNESS 81
615 CORONARY ARTERY OCCLUSION 80
616 EYE INFECTION 80
617 FREQUENT BOWEL MOVEMENTS 80
618 HYPERGLYCAEMIA 80
619 PRODUCT PHYSICAL ISSUE 80
620 SPUTUM INCREASED 80
621 TUBULOINTERSTITIAL NEPHRITIS 80
622 CREPITATIONS 79
623 EOSINOPHIL COUNT ABNORMAL 79
624 PARANASAL SINUS DISCOMFORT 79
625 PHARYNGOLARYNGEAL PAIN 79
626 SKIN HAEMORRHAGE 79
627 DENTAL CARIES 78
628 DRUG WITHDRAWAL SYNDROME 78
629 EMOTIONAL DISORDER 78
630 MUSCLE STRAIN 78
631 PRODUCT AVAILABILITY ISSUE 78
632 QUALITY OF LIFE DECREASED 78
633 REBOUND ACID HYPERSECRETION 78
634 SCIATICA 78
635 SNORING 78
636 WITHDRAWAL SYNDROME 78
637 BRONCHIAL HYPERREACTIVITY 77
638 CARDIAC OPERATION 77
639 CHOKING SENSATION 77
640 DEPRESSIVE SYMPTOM 77
641 FORCED VITAL CAPACITY DECREASED 77
642 JOINT DISLOCATION 77
643 ORAL DISORDER 77
644 PARAESTHESIA ORAL 77
645 STENT PLACEMENT 77
646 ACTIVITIES OF DAILY LIVING IMPAIRED 76
647 PRODUCT ADMINISTRATION ERROR 76
648 VIRAL UPPER RESPIRATORY TRACT INFECTION 76
649 AFFECTIVE DISORDER 75
650 HIP ARTHROPLASTY 75
651 HYPOGLYCAEMIA 75
652 IMPAIRED GASTRIC EMPTYING 75
653 MASS 75
654 OSTEONECROSIS 75
655 PHOTOPHOBIA 75
656 SKIN BURNING SENSATION 75
657 ALANINE AMINOTRANSFERASE INCREASED 74
658 CYST 74
659 NASAL DISORDER 74
660 PRODUCT ADMINISTRATION INTERRUPTED 74
661 PULMONARY PAIN 74
662 TOXICITY TO VARIOUS AGENTS 74
663 UPPER GASTROINTESTINAL HAEMORRHAGE 74
664 COAGULOPATHY 73
665 FLUID OVERLOAD 73
666 MENTAL STATUS CHANGES 73
667 MUSCULOSKELETAL DISORDER 73
668 NERVE COMPRESSION 73
669 PHOTOSENSITIVITY REACTION 73
670 SUICIDE ATTEMPT 73
671 TOOTH FRACTURE 73
672 ANAPHYLACTIC SHOCK 72
673 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 72
674 MOUTH ULCERATION 72
675 PSYCHOLOGICAL TRAUMA 72
676 RESPIRATORY SYNCYTIAL VIRUS INFECTION 72
677 SKIN INFECTION 72
678 SPINAL COMPRESSION FRACTURE 72
679 WEIGHT FLUCTUATION 72
680 INTERNATIONAL NORMALISED RATIO INCREASED 71
681 LOWER GASTROINTESTINAL HAEMORRHAGE 71
682 SKIN CANCER 71
683 BRADYCARDIA 70
684 CARDIOMEGALY 70
685 LACERATION 70
686 LUNG OPACITY 70
687 POOR VENOUS ACCESS 70
688 CAPILLARITIS 69
689 DYSARTHRIA 69
690 HAEMATEMESIS 69
691 INTERNAL HAEMORRHAGE 69
692 NERVE INJURY 69
693 RENAL FAILURE ACUTE 69
694 TOOTH LOSS 69
695 ABNORMAL LOSS OF WEIGHT 68
696 AORTIC ANEURYSM 68
697 DEVICE FAILURE 68
698 DRUG DISPENSING ERROR 68
699 EXERCISE TOLERANCE DECREASED 68
700 FRUSTRATION TOLERANCE DECREASED 68
701 INJECTION SITE URTICARIA 68
702 PLASMA CELL MYELOMA 68
703 HYPERPARATHYROIDISM SECONDARY 67
704 INCREASED APPETITE 67
705 MENTAL IMPAIRMENT 67
706 PNEUMONIA ASPIRATION 67
707 POST PROCEDURAL INFECTION 67
708 VENTRICULAR HYPOKINESIA 67
709 WOUND INFECTION 67
710 ACCIDENTAL OVERDOSE 66
711 ATOPY 66
712 ATRIAL FLUTTER 66
713 CHOLECYSTECTOMY 66
714 DYSKINESIA 66
715 HYPERLIPIDAEMIA 66
716 MUSCLE TWITCHING 66
717 TOTAL LUNG CAPACITY INCREASED 66
718 CARDIO-RESPIRATORY ARREST 65
719 DERMATITIS 65
720 HAND FRACTURE 65
721 MULTIPLE FRACTURES 65
722 MUSCLE TIGHTNESS 65
723 PERFUME SENSITIVITY 65
724 PRESCRIBED UNDERDOSE 65
725 BRONCHIAL OBSTRUCTION 64
726 CARDIOMYOPATHY 64
727 HYPERVENTILATION 64
728 LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR 64
729 NEEDLE ISSUE 64
730 SINUS OPERATION 64
731 DEVICE BREAKAGE 62
732 FACIAL PAIN 62
733 HAIR TEXTURE ABNORMAL 62
734 INCREASED TENDENCY TO BRUISE 62
735 INFUSION SITE PRURITUS 62
736 LUNG DIFFUSION TEST DECREASED 62
737 PANCYTOPENIA 62
738 PRODUCT TASTE ABNORMAL 62
739 TENDON RUPTURE 62
740 BASAL CELL CARCINOMA 61
741 CYANOSIS 61
742 DRUG PRESCRIBING ERROR 61
743 EOSINOPHIL COUNT DECREASED 61
744 INTENTIONAL DEVICE MISUSE 61
745 NEPHROPATHY 61
746 PRODUCT PRESCRIBING ERROR 61
747 REHABILITATION THERAPY 61
748 ADDISON^S DISEASE 60
749 ARTHRITIS INFECTIVE 60
750 HAEMORRHAGIC ANAEMIA 60
751 HEREDITARY ANGIOEDEMA 60
752 IRON DEFICIENCY ANAEMIA 60
753 IRRITABLE BOWEL SYNDROME 60
754 LUNG CONSOLIDATION 60
755 MULTIPLE ORGAN DYSFUNCTION SYNDROME 60
756 SKIN ABRASION 60
757 SMALL INTESTINAL OBSTRUCTION 60
758 BRONCHITIS CHRONIC 59
759 CHROMATURIA 59
760 CONVULSION 59
761 COVID-19 PNEUMONIA 59
762 GINGIVAL DISORDER 59
763 LEUKOCYTOSIS 59
764 MOOD ALTERED 59
765 MOOD SWINGS 59
766 MYASTHENIA GRAVIS 59
767 OXYGEN SATURATION ABNORMAL 59
768 PHARYNGEAL SWELLING 59
769 SJOGREN^S SYNDROME 59
770 SKIN FISSURES 59
771 THIRST 59
772 AIRWAY REMODELLING 58
773 APPENDICITIS 58
774 FULL BLOOD COUNT DECREASED 58
775 HYPERKALAEMIA 58
776 INFUSION SITE HAEMORRHAGE 58
777 INJECTION SITE WARMTH 58
778 LIVER FUNCTION TEST ABNORMAL 58
779 LYMPHOCYTE COUNT DECREASED 58
780 NOCTURIA 58
781 PLEURISY 58
782 POST-TRAUMATIC STRESS DISORDER 58
783 SCAB 58
784 ABORTION SPONTANEOUS 57
785 BLOOD CALCIUM INCREASED 57
786 FOOD POISONING 57
787 HAIR COLOUR CHANGES 57
788 MUSCLE ATROPHY 57
789 OXYGEN SUPPLEMENTATION 57
790 TRANSFUSION 57
791 TROPONIN INCREASED 57
792 BLADDER DISORDER 56
793 CEREBRAL HAEMORRHAGE 56
794 DEPRESSED LEVEL OF CONSCIOUSNESS 56
795 DIPLOPIA 56
796 PARKINSON^S DISEASE 56
797 PSYCHOMOTOR HYPERACTIVITY 56
798 RASH GENERALISED 56
799 RED CELL DISTRIBUTION WIDTH INCREASED 56
800 TASTE DISORDER 56
801 ADRENAL SUPPRESSION 55
802 BRAIN FOG 55
803 CONCOMITANT DISEASE AGGRAVATED 55
804 HEART SOUNDS 55
805 MICTURITION URGENCY 55
806 PLATELET COUNT INCREASED 55
807 TACHYARRHYTHMIA 55
808 TEMPERATURE INTOLERANCE 55
809 VENTRICULAR FIBRILLATION 55
810 BEDRIDDEN 54
811 BLOOD POTASSIUM INCREASED 54
812 SKIN ATROPHY 54
813 TACHYPNOEA 54
814 ERUCTATION 53
815 EXOSTOSIS 53
816 MENISCUS INJURY 53
817 PAIN OF SKIN 53
818 PANIC REACTION 53
819 PRODUCT PRESCRIBING ISSUE 53
820 SPINAL DISORDER 53
821 DEVICE USE ISSUE 52
822 EOSINOPHILIC PNEUMONIA 52
823 INCORRECT DOSAGE ADMINISTERED 52
824 PAINFUL RESPIRATION 52
825 PELVIC PAIN 52
826 PRODUCT DISPENSING ERROR 52
827 RESPIRATORY TRACT IRRITATION 52
828 WRONG TECHNIQUE IN DRUG USAGE PROCESS 52
829 ALLERGIC GRANULOMATOUS ANGIITIS 51
830 ASPERGILLUS INFECTION 51
831 BLOOD GLUCOSE ABNORMAL 51
832 BRONCHIAL WALL THICKENING 51
833 DEVICE DISLOCATION 51
834 EYE DISCHARGE 51
835 HEPATIC CIRRHOSIS 51
836 HYPOKINESIA 51
837 INFUSION SITE DISCHARGE 51
838 LUNG INFILTRATION 51
839 NEUTROPHIL COUNT DECREASED 51
840 NEUTROPHIL COUNT INCREASED 51
841 RENAL TUBULAR NECROSIS 51
842 SPUTUM RETENTION 51
843 UMBILICAL HERNIA 51
844 VITAMIN D DECREASED 51
845 ARTHROPOD BITE 50
846 BLADDER CANCER 50
847 DEVICE LEAKAGE 50
848 HYPOAESTHESIA ORAL 50
849 KNEE OPERATION 50
850 LYMPHOMA 50
851 MICROANGIOPATHY 50
852 NASAL DRYNESS 50
853 ABDOMINAL HERNIA 49
854 ABDOMINAL PAIN LOWER 49
855 BIPOLAR DISORDER 49
856 BLOOD PRESSURE DIASTOLIC INCREASED 49
857 BRONCHOPULMONARY ASPERGILLOSIS ALLERGIC 49
858 EOSINOPHILIC MYOCARDITIS 49
859 GLUCOSE TOLERANCE IMPAIRED 49
860 IRON DEFICIENCY 49
861 PRODUCT DISTRIBUTION ISSUE 49
862 SKIN REACTION 49
863 VAGINAL HAEMORRHAGE 49
864 CARDIAC SEPTAL DEFECT 48
865 CARDIOGENIC SHOCK 48
866 CYSTIC FIBROSIS RESPIRATORY INFECTION SUPPRESSION 48
867 DIABETES MELLITUS INADEQUATE CONTROL 48
868 DIZZINESS POSTURAL 48
869 LIGAMENT RUPTURE 48
870 LYMPHOPENIA 48
871 MUSCLE DISORDER 48
872 NOCTURNAL DYSPNOEA 48
873 ORTHOSTATIC HYPOTENSION 48
874 PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE 48
875 PSYCHOTIC DISORDER 48
876 RENAL CYST 48
877 SINUS HEADACHE 48
878 SMOKE SENSITIVITY 48
879 VOCAL CORD DISORDER 48
880 WALKING AID USER 48
881 WHEELCHAIR USER 48
882 BLOOD UREA INCREASED 47
883 CENTRAL NERVOUS SYSTEM MASS 47
884 CORONARY ARTERY BYPASS 47
885 ELECTROCARDIOGRAM QT PROLONGED 47
886 EMERGENCY CARE 47
887 EMERGENCY CARE EXAMINATION 47
888 ENDOTRACHEAL INTUBATION 47
889 GINGIVAL PAIN 47
890 HOARSENESS 47
891 INFUSION SITE EXTRAVASATION 47
892 INITIAL INSOMNIA 47
893 INTRAOCULAR PRESSURE INCREASED 47
894 LUNG TRANSPLANT 47
895 NEOPLASM PROGRESSION 47
896 NERVOUS SYSTEM DISORDER 47
897 PARANASAL SINUS HYPERSECRETION 47
898 PAROSMIA 47
899 PEAK EXPIRATORY FLOW RATE DECREASED 47
900 PRODUCT CLEANING INADEQUATE 47
901 TONGUE DISORDER 47
902 WALL MOTION SCORE INDEX ABNORMAL 47
903 AORTIC STENOSIS 46
904 BENIGN PROSTATIC HYPERPLASIA 46
905 BLOOD ALKALINE PHOSPHATASE INCREASED 46
906 EUPHORIC MOOD 46
907 HAIR DISORDER 46
908 LOCAL SWELLING 46
909 NASAL TURBINATE HYPERTROPHY 46
910 PERIPHERAL COLDNESS 46
911 PROSTATOMEGALY 46
912 DRUG ABUSE 45
913 DYSPNOEA AT REST 45
914 FOOT DEFORMITY 45
915 HOSPICE CARE 45
916 HYPERCAPNIA 45
917 MADAROSIS 45
918 ORAL FUNGAL INFECTION 45
919 RENAL CANCER 45
920 SOMNAMBULISM 45
921 STRESS FRACTURE 45
922 GRANULOMA 44
923 HYPOPHOSPHATAEMIA 44
924 POSTOPERATIVE WOUND INFECTION 44
925 RIGHT VENTRICULAR FAILURE 44
926 SENSATION OF FOREIGN BODY 44
927 BLOOD MAGNESIUM DECREASED 43
928 BOWEL MOVEMENT IRREGULARITY 43
929 INCONTINENCE 43
930 RASH PAPULAR 43
931 SEDATION 43
932 SENSORY DISTURBANCE 43
933 BLOOD CREATINE PHOSPHOKINASE INCREASED 42
934 BRONCHIAL SECRETION RETENTION 42
935 COLON CANCER 42
936 DIVERTICULUM 42
937 DRUG EFFECT LESS THAN EXPECTED 42
938 FRACTURE 42
939 GASTROINTESTINAL INFECTION 42
940 GLYCOSYLATED HAEMOGLOBIN INCREASED 42
941 HAEMORRHAGIC DIATHESIS 42
942 HYPOCALCAEMIA 42
943 INCREASED VISCOSITY OF BRONCHIAL SECRETION 42
944 MELAENA 42
945 NEOPLASM 42
946 PRODUCT PREPARATION ERROR 42
947 PRODUCT USE COMPLAINT 42
948 RETINAL DETACHMENT 42
949 SPUTUM PURULENT 42
950 TOOTH EXTRACTION 42
951 ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED 41
952 ANAL INCONTINENCE 41
953 AUTOIMMUNE DISORDER 41
954 BLINDNESS UNILATERAL 41
955 DEVICE OCCLUSION 41
956 DRUG EXPOSURE DURING PREGNANCY 41
957 INTENTIONAL OVERDOSE 41
958 OBSTRUCTION 41
959 OESOPHAGITIS 41
960 OVARIAN CYST 41
961 PHARYNGEAL DISORDER 41
962 SCOLIOSIS 41
963 ASTHMATIC CRISIS 40
964 BRONCHIAL HAEMORRHAGE 40
965 BRONCHIAL NEOPLASM 40
966 CHRONIC KIDNEY DISEASE-MINERAL AND BONE DISORDER 40
967 DEVICE RELATED INFECTION 40
968 DIABETIC NEUROPATHY 40
969 ENDOMETRIAL ABLATION 40
970 GROIN PAIN 40
971 INFUSION SITE BRUISING 40
972 MENIERE^S DISEASE 40
973 METABOLIC ACIDOSIS 40
974 OESOPHAGEAL CANDIDIASIS 40
975 RESPIRATORY TRACT INFECTION VIRAL 40
976 TRANSAMINASES INCREASED 40
977 VITREOUS FLOATERS 40
978 ARTERIAL OCCLUSIVE DISEASE 39
979 CARBON DIOXIDE INCREASED 39
980 CARDIAC FLUTTER 39
981 EAR DISORDER 39
982 ESCHERICHIA INFECTION 39
983 EYE INFLAMMATION 39
984 GLOMERULAR FILTRATION RATE DECREASED 39
985 HEPATIC FAILURE 39
986 HIP SURGERY 39
987 HORDEOLUM 39
988 INCORRECT DOSE ADMINISTERED BY DEVICE 39
989 LEUKAEMIA 39
990 PERICARDITIS 39
991 RHINOVIRUS INFECTION 39
992 UPPER RESPIRATORY TRACT CONGESTION 39
993 ABSCESS 38
994 BLOOD BILIRUBIN INCREASED 38
995 BLOOD IMMUNOGLOBULIN G DECREASED 38
996 CARDIOVASCULAR DISORDER 38
997 INTERVERTEBRAL DISC DISORDER 38
998 ODYNOPHAGIA 38
999 PARALYSIS 38